Oruka Therapeutics (ORKA) Operating Leases (2020 - 2026)
Oruka Therapeutics' quarterly Operating Leases came in at $1.1 million in Q1 2026, up 69.73% year-on-year from $664000.0 in Q1 2025, and down 14.17% quarter-over-quarter from $1.3 million in Q4 2025.
Oruka Therapeutics has reported Operating Leases for 7 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 69.73% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 69.73% YoY), and the FY2025 full-year result was $1.3 million, up 73.91% from the prior year.
- Operating Leases for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
- The five-year high for Operating Leases was $1.7 million in Q2 2025, with the low at $24000.0 in Q2 2024.
- Average Operating Leases over 5 years is $616470.6, with a median of $435000.0 recorded in 2022.
- Year-over-year, Operating Leases tumbled 92.71% in 2024 and jumped 6841.67% in 2025.
- Tracing ORKA's Operating Leases over 5 years: stood at $280000.0 in 2022, then retreated by 27.14% to $204000.0 in 2023, then jumped by 270.1% to $755000.0 in 2024, then jumped by 73.91% to $1.3 million in 2025, then slipped by 14.17% to $1.1 million in 2026.
- The last three Operating Leases figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 664,000.00 |
| Dec 31, 2024 | 755,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 204,000.00 |
| Sep 30, 2023 | 224,000.00 |
| Jun 30, 2023 | 329,000.00 |
| Mar 31, 2023 | 357,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Sep 30, 2022 | 301,000.00 |
| Jun 30, 2022 | 435,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 383,000.00 |
| Sep 30, 2021 | 410,000.00 |
| Jun 30, 2021 | 435,000.00 |
| Mar 31, 2021 | 450,000.00 |
| Dec 31, 2020 | 409,000.00 |